An Approach to the Validation of Flow Cytometry Methods

被引:31
作者
Cunliffe, Jo [3 ]
Derbyshire, Nicola [3 ]
Keeler, Sue [1 ,2 ]
Coldwell, Ruth [1 ,2 ]
机构
[1] AstraZeneca R&D Charnwood, Clin Pharmacol, Loughborough LE11 5RH, Leics, England
[2] AstraZeneca R&D Charnwood, DMPK, Loughborough LE11 5RH, Leics, England
[3] AstraZeneca R&D, Safety Assessment, Macclesfield SK10 4TG, Cheshire, England
关键词
biomarker; flow cytometry; GLP; method validation; regulatory; BIOANALYTICAL METHODS; DRUG DEVELOPMENT;
D O I
10.1007/s11095-009-9972-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This publication outlines an approach for the validation of flow cytometry methods used in the analysis of a wide range of biomarkers. It is written as a guidance document for method validation in a GLP environment, and from the viewpoint of the pharmaceutical industry, but its relevance is wide-ranging. The approach to method validation described is intended as a starting point for further discussion, as well as providing reference material to colleagues developing fit-for-purpose flow cytometry methods. Pre-validation steps are discussed as prerequisite assessments to determine method and reagent suitability, and to minimise variables during the full validation process. The guide to method validation takes account of the many flow cytometry assay types in use, and provides guidance on the types of assessments necessary to produce a fit-for-purpose method suitable for use in a regulatory environment.
引用
收藏
页码:2551 / 2557
页数:7
相关论文
共 15 条
[1]  
*AAPS, 2008, AAPS WORKSH CURR TOP
[2]   Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species [J].
Brodersen, R ;
Bijlsma, F ;
Gori, K ;
Jensen, KT ;
Chen, W ;
Dominguez, J ;
Haverson, K ;
Moore, PF ;
Saalmüller, A ;
Sachs, D ;
Slierendrecht, WJ ;
Stokes, C ;
Vainio, O ;
Zuckermann, F ;
Aasted, B .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 64 (01) :1-13
[3]   Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: Influence of age, sex, and race and comparison with other published studies [J].
Chng, WJ ;
Tan, GB ;
Kuperan, P .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) :168-173
[4]   Biomarker method validation in anticancer drug development [J].
Cummings, J. ;
Ward, T. H. ;
Greystoke, A. ;
Ranson, M. ;
Dive, C. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (04) :646-656
[5]  
*HLTH SAF, 1999, 3106 HLTH SAF
[6]   Differential pattern of human blood neutrophil activation after stimulation with organic dust in vitro and in vivo [J].
Jonsson, Eva Wikstrom ;
Palmberg, Lena .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2007, 49 (02) :131-138
[7]   VALIDATION OF BIOANALYTICAL METHODS [J].
KARNES, HT ;
SHIU, G ;
SHAH, VP .
PHARMACEUTICAL RESEARCH, 1991, 8 (04) :421-426
[8]   Fit-for-purpose method development and validation for successful biomarker measurement [J].
Lee, JW ;
Devanarayan, V ;
Barrett, YC ;
Weiner, R ;
Allinson, J ;
Fountain, S ;
Keller, S ;
Weinryb, I ;
Green, M ;
Duan, L ;
Rogers, JA ;
Millham, R ;
O'Brien, PJ ;
Sailstad, J ;
Khan, M ;
Ray, C ;
Wagner, JA .
PHARMACEUTICAL RESEARCH, 2006, 23 (02) :312-328
[9]   Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: A conference report [J].
Lee, JW ;
Weiner, RS ;
Sailstad, JM ;
Bowsher, RR ;
Knuth, DW ;
O'Brien, PJ ;
Fourcroy, JL ;
Dixit, R ;
Pandite, L ;
Pietrusko, RG ;
Soares, HD ;
Quarmby, V ;
Vesterqvist, OL ;
Potter, DM ;
Witliff, JL ;
Fritche, HA ;
O'Leary, T ;
Perlee, L ;
Kadam, S ;
Wagner, JA .
PHARMACEUTICAL RESEARCH, 2005, 22 (04) :499-511
[10]   Confirmatory reanalysis of incurred bioanalytical samples [J].
Rocci, Mario L., Jr. ;
Devanarayan, Viswanath ;
Haughey, David B. ;
Jardieu, Paula .
AAPS JOURNAL, 2007, 9 (03) :E336-E343